GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
Synonyms: HPRP-A1 | PL-18
Compound class:
Peptide
Comment: Gosteganan is the INN (included in WHO INN proposed list 133, 10th July 2025; formerly PL-18) for a broad-spectrum antimicrobial peptide derived from the N-terminus of the Helicobacter pylori ribosomal protein L1 (RpL1). Gosteganan demonstrates antibacterial activity against both against Gram-negative and Gram-positive bacteria and also has antifungal activity [2]. It is claimed in patent WO2012142855A1 (ProteLight Pharma) [1].
|
|
References |
1. Chen Y, Chen M, Huang Y, Li Y, Wang Y, Qu L, Wang W. (2012)
Antibiotic peptide and preparation method therefor and application thereof. Patent number: WO2012142855A1. Assignee: Jiangsu Protelight Pharmaceutical & Biotechnology. Priority date: 17/01/2012. Publication date: 26/10/2012. |
2. Feng Q, Huang Y, Chen M, Li G, Chen Y. (2015)
Functional synergy of α-helical antimicrobial peptides and traditional antibiotics against Gram-negative and Gram-positive bacteria in vitro and in vivo. Eur J Clin Microbiol Infect Dis, 34 (1): 197-204. [PMID:25169965] |